Results 11 to 20 of about 12,563,372 (298)
TREATMENT OF GROWTH-HORMONE DEFICIENCY WITH GROWTH-HORMONE-RELEASING HORMONE
The Lancet, 1987 18 prepubertal growth-hormone (GH)-deficient children were treated with twice-daily subcutaneous injections of a growth-hormone-releasing hormone analogue, GHRH (1-29) NH2. In 12 of the children the height velocity rose on GHRH treatment, and 8 were judged to have shown a worthwhile response to therapy in that their height velocities during the first 6
Ross, R.J.M. +8 more
openaire +6 more sources
Parents' views on growth hormone treatment for their children: psychosocial issues
Patient Preference and Adherence, 2012 Nadine van Dongen,1 Ad A Kaptein21Patient Intelligence Panel Health Ltd, London, United Kingdom; 2Section Medical Psychology, Leiden University Medical Centre, Leiden, The NetherlandsBackground: We evaluated the opinions of parents in The Netherlands ...
van Dongen N, Kaptein AA
doaj +1 more source
Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®
Patient Preference and Adherence, 2011 Kevin CJ Yuen1, Rakesh Amin21Division of Endocrinology, Diabetes and Clinical Nutrition, Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA; 2Barts and The London Children’s Hospital, London, UKAbstract ...
Kevin CJ Yuen, Rakesh Amin
doaj +1 more source
Treatment of Growth Hormone Deficiency in Adults
Hormone Research in Paediatrics, 2009 <i>Background:</i> The Growth Hormone Research Society held a Consensus Workshop in Sydney, Australia, in March 2007 to review advances in the management of growth hormone (GH) deficiency in adults and to update consensus recommendations. <i>Objective:</i> This short review summarizes key background information presented at the ...
Johannsson, Gudmundur,
openaire +3 more sources
The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency [PDF]
Endocrine Connections, 2017 The fundamental challenge of developing a long-acting growth hormone (LAGH) is to create a more convenient growth hormone (GH) dosing profile while retaining the excellent safety, efficacy and tolerability of daily GH.
Kennett Sprogøe +3 more
doaj +3 more sources
Recombinant human growth hormone in the treatment of Turner syndrome
Therapeutics and Clinical Risk Management, 2008 Bessie E SpiliotisDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Patras, School of Medicine, Patras, GreeceAbstract: Turner syndrome (TS) is a common chromosomal disorder in women that is associated with the ...
Bessie E Spiliotis
doaj +1 more source
Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin)
Biologics: Targets & Therapy, 2008 Dana S HardinOhio State University and Columbus Children’s Hospital, Columbus, Ohio, USAAbstract: Somatotropin (growth hormone, GH) of recombinant DNA origin has provided a readily available and safe drug that has greatly improved management of
Dana S Hardin
doaj +1 more source
Growth hormone treatment for growth hormone deficient adults [PDF]
Journal of Clinical Pharmacy and Therapeutics, 1996 Growth hormone (GH) deficiency in adults is now recognized as a clinical syndrome with characteristic signs and symptoms. Numerous trials with daily subcutaneous biosynthetic human growth hormone (hGH) have been conducted in this patient group. Generally, improvements in insulin-like growth factor levels, decreases in total fat mass and increases in ...
W, Clark, M J, Kendall
openaire +2 more sources
Growth hormone releasing hormone or growth hormone treatment in growth hormone insufficiency? [PDF]
Archives of Disease in Childhood, 1988 Sixteen prepubertal children who were insufficient for growth hormone were treated with growth hormone releasing hormone (GHRH) 1-40 and GHRH 1-29 for a mean time of nine months (range 6-12 months) with each peptide. Eleven children received GHRH 1-40 in four subcutaneous nocturnal pulses (dose 4-8 micrograms/kg/day) and eight (three of whom were also ...
P J, Smith, C G, Brook
openaire +2 more sources
Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs
Frontiers in Endocrinology, 2021 Daily recombinant human GH (rhGH) is currently approved for use in children and adults with GH deficiency (GHD) in many countries with relatively few side-effects.
Kevin C. J. Yuen +3 more
doaj +1 more source